Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 98 results
A vaccine vial on a filling station in a pharmaceutical setting.

Jul 22, 2026

Single Use Support speeds design cycle for pharma

Siemens' collaboration with Single Use Support is revolutionizing the pharmaceutical design cycle through innovative technologies aimed at enhancing efficiency in handling sensitive liquids like vaccines.Single Use Support, which operates in Austria and the USA, specializes in single-use technologies for the pharmaceutical sector, focusing on the filling, freezing, storing, and transporting of liquid medicines. By integrating Siemens Xcelerator, particularly Designcenter™ and Teamcenter®, the co
A minimalist illustration of a pill and a data stream in a dark palette.

Jul 18, 2026

HRV Pharma Introduces RIKO™, India’s first AI-Native Pharmaceutical Operating System

HRV Pharma has launched RIKO™, an innovative AI-native pharmaceutical operating system designed to enhance decision-making across the pharmaceutical value chain.RIKO™ leverages seven years of HRV Pharma's operational experience and institutional knowledge, differentiating itself from traditional AI by utilizing real-world data rather than solely public information. This self-learning system employs ten federated reasoning models that continuously adapt, enabling it to predict risks and identify
A glass vial with a drug compound in a manufacturing facility

Jul 18, 2026

Bora and Insilico’s $2.5B AI Powered Manufacturing Alliance - and What Maryland Adds to the Equation

Bora Pharmaceuticals and Insilico Medicine have formed a strategic alliance aimed at revolutionizing drug development through an AI-integrated approach, with a potential value exceeding $2.5 billion.The partnership combines Insilico’s Pharma.AI platform with Bora’s manufacturing capabilities, creating a seamless flow from drug discovery to market execution. This integration is designed to enhance efficiency, reduce errors, and improve reliability for Bora's contract development and manufacturing
A vial of liquid on a workbench in a pharmaceutical lab

Jul 17, 2026

Katalyze AI Raises $10.5M to Bring Agentic AI Systems to Pharmaceutical Manufacturing

Katalyze AI has successfully secured $10.5 million in seed funding aimed at developing an advanced operating system designed specifically for pharmaceutical manufacturing.This San Francisco-based startup, founded by Reza Farahani and others, focuses on creating specialized AI agents that leverage verified operational data, distinguishing itself from traditional general-purpose AI models. Their innovative platform is engineered to integrate various data sources, including Manufacturing Execution
A green plant specimen in a dimly lit laboratory setting, symbolizing sustainable practices in green pharma.

Jul 16, 2026

Telangana, Microsoft, Join Hands for Green Pharma AI Centre

The Telangana government has announced a collaboration with Microsoft and other organizations to establish a Green Skills and Applied AI Centre of Excellence (CoE) focused on Green Pharma in Hyderabad.Set to be operational by August 2026, this initiative aims to equip the youth with skills that merge artificial intelligence with sustainable manufacturing practices, thereby bolstering the state's life sciences and green manufacturing sectors. The project aligns with Telangana's Next-Generation Li
A minimalist illustration of a test tube and an AI chip in a dark palette.

Jul 16, 2026

BioBuzz Awarded State Grant to Launch AI-GMP Training Accelerator for Maryland's Biotech Workforce

BioBuzz Networks has been awarded a grant to establish an AI-GMP Training Accelerator, aimed at enhancing the skills of Maryland's biotech workforce as part of the state’s broader initiative to integrate AI into regulated industries.The Maryland Lighthouse Industries Upskilling and Reskilling Program, backed by a $1.23 million investment, will enable BioBuzz to train nearly 600 workers in the life sciences sector. This program focuses on upskilling existing employees at biotech development and m
A minimalist illustration of a bioreactor representing biomanufacturing.

Jul 15, 2026

Europe widens biomanufacturing gap between EU and US

A recent report from GlobalData highlights a significant widening of the biomanufacturing gap between the US and the EU, with European facilities increasingly favored for drug manufacturing contracts. The analysis indicates that over 50% of new drugs in 2025 were associated with European manufacturing sites, a notable increase from just 25% in 2023. In contrast, the US's share of newly approved drug contracts has stagnated at approximately 18% since 2024. This trend reflects a strategic shift in
A minimalist illustration of a pill and a factory, symbolizing pharmaceutical manufacturing.

Jul 15, 2026

Generative AI Moves From Drug Discovery to Drug Factories in $2.5B Bora Deal

Insilico Medicine and Bora Pharmaceuticals have formed a strategic alliance to integrate generative AI technologies into pharmaceutical manufacturing, potentially valued at over $2.5 billion. This partnership aims to extend AI's role, which has predominantly been in drug discovery, into the more complex realm of drug production.The collaboration focuses on leveraging Insilico's AI platforms, PandaOmics and Chemistry42, which have been instrumental in identifying drug targets and designing molecu
A minimalist representation of a gear and circuit board in a dark palette, symbolizing medical technology collaboration.

Jul 7, 2026

PDV MedTech Inc.; Corscience

PDV MedTech and Corscience have formed a strategic partnership aimed at enhancing the development and manufacturing of medical technologies across the U.S. and Europe.This collaboration merges Corscience's engineering expertise in complex medical devices with PDV MedTech's robust U.S. manufacturing capabilities. The goal is to streamline the journey from concept to commercialization for safety-critical medical devices, addressing common challenges such as regulatory compliance, design for manufa
A test tube in a dimly lit lab

Jul 6, 2026

Katalyze AI raises $10.5M to deploy agent teams

Katalyze AI has successfully secured $10.5 million in seed funding aimed at enhancing its agent teams focused on pharmaceutical manufacturing and life sciences operations.This funding round, reported by BetaKit and TechStartups, signals a significant shift in the application of agentic AI, moving from experimental demonstrations to practical applications within regulated environments. Key integrations with systems such as Manufacturing Execution Systems (MES), Laboratory Information Management S
A minimalist illustration of a pill bottle and an AI agent silhouette on a solid background.

Jul 6, 2026

Katalyze AI thinks the future of pharma operations is teams of AI agents

Katalyze AI has secured $10.5 million in seed funding to enhance drug development through AI-driven operational efficiencies.The startup, Katalyze AI, is developing a platform designed to enable pharmaceutical companies to assemble teams of AI agents for various tasks, including engineering and manufacturing. This innovative approach aims to streamline operations within the pharma sector, which traditionally faces lengthy and costly drug development processes. With the recent funding led by Bonf
A minimalist representation of financial growth with a dollar sign and a circular shape.

Jul 6, 2026

Katalyze AI Raises $10.5M in Seed Funding

Katalyze AI has successfully secured $10.5 million in Seed funding to enhance its innovative operating system tailored for pharmaceutical companies.The funding round, spearheaded by Bonfire Ventures, saw participation from Inovia Capital, Ripple Ventures, Alumni Ventures, and notable angel investors such as Gokul Rajaram and Farzad Soleimani. This financial boost is aimed at expanding Katalyze AI's operations and furthering its development initiatives.Under the leadership of CEO Reza Farahani, K